These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
443 related articles for article (PubMed ID: 31559693)
1. Down-regulation of interferon regulatory factor 2 binding protein 2 suppresses gastric cancer progression by negatively regulating connective tissue growth factor. Yao Y; Wang Y; Li L; Xiang X; Li J; Chen J; Liu Z; Huang S; Xiong J; Deng J J Cell Mol Med; 2019 Dec; 23(12):8076-8089. PubMed ID: 31559693 [TBL] [Abstract][Full Text] [Related]
2. miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis. Kang W; Huang T; Zhou Y; Zhang J; Lung RWM; Tong JHM; Chan AWH; Zhang B; Wong CC; Wu F; Dong Y; Wang S; Yang W; Pan Y; Chak WP; Cheung AHK; Pang JCS; Yu J; Cheng ASL; To KF Cell Death Dis; 2018 Jan; 9(2):92. PubMed ID: 29367737 [TBL] [Abstract][Full Text] [Related]
3. TEAD4 modulated LncRNA MNX1-AS1 contributes to gastric cancer progression partly through suppressing BTG2 and activating BCL2. Shuai Y; Ma Z; Liu W; Yu T; Yan C; Jiang H; Tian S; Xu T; Shu Y Mol Cancer; 2020 Jan; 19(1):6. PubMed ID: 31924214 [TBL] [Abstract][Full Text] [Related]
4. A novel YAP1/SLC35B4 regulatory axis contributes to proliferation and progression of gastric carcinoma. Liu J; Zhao X; Wang K; Zhang X; Yu Y; Lv Y; Zhang S; Zhang L; Guo Y; Li Y; Yang A; Zhang R; Li J Cell Death Dis; 2019 Jun; 10(6):452. PubMed ID: 31175271 [TBL] [Abstract][Full Text] [Related]
5. Circular RNA CircCACTIN Promotes Gastric Cancer Progression by Sponging MiR-331-3p and Regulating TGFBR1 Expression. Zhang L; Song X; Chen X; Wang Q; Zheng X; Wu C; Jiang J Int J Biol Sci; 2019; 15(5):1091-1103. PubMed ID: 31182928 [No Abstract] [Full Text] [Related]
6. MicroRNA-145 Inhibits Cell Migration and Invasion and Regulates Epithelial-Mesenchymal Transition (EMT) by Targeting Connective Tissue Growth Factor (CTGF) in Esophageal Squamous Cell Carcinoma. Han Q; Zhang HY; Zhong BL; Wang XJ; Zhang B; Chen H Med Sci Monit; 2016 Oct; 22():3925-3934. PubMed ID: 27771733 [TBL] [Abstract][Full Text] [Related]
7. TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis. Zhou Y; Huang T; Zhang J; Wong CC; Zhang B; Dong Y; Wu F; Tong JHM; Wu WKK; Cheng ASL; Yu J; Kang W; To KF Oncogene; 2017 Nov; 36(47):6518-6530. PubMed ID: 28759040 [TBL] [Abstract][Full Text] [Related]
8. Integrative genomics analysis reveals the multilevel dysregulation and oncogenic characteristics of TEAD4 in gastric cancer. Lim B; Park JL; Kim HJ; Park YK; Kim JH; Sohn HA; Noh SM; Song KS; Kim WH; Kim YS; Kim SY Carcinogenesis; 2014 May; 35(5):1020-7. PubMed ID: 24325916 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA LINC00649 regulates YES-associated protein 1 (YAP1)/Hippo pathway to accelerate gastric cancer (GC) progression via sequestering miR-16-5p. Wang H; Di X; Bi Y; Sun S; Wang T Bioengineered; 2021 Dec; 12(1):1791-1802. PubMed ID: 33975517 [TBL] [Abstract][Full Text] [Related]
10. miR-1254 inhibits cell proliferation, migration, and invasion by down-regulating Smurf1 in gastric cancer. Jiang M; Shi L; Yang C; Ge Y; Lin L; Fan H; He Y; Zhang D; Miao Y; Yang L Cell Death Dis; 2019 Jan; 10(1):32. PubMed ID: 30631050 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA HCG18 up-regulates the expression of WIPF1 and YAP/TAZ by inhibiting miR-141-3p in gastric cancer. Liu Y; Lin W; Dong Y; Li X; Lin Z; Jia J; Zou W; Pan Y Cancer Med; 2020 Sep; 9(18):6752-6765. PubMed ID: 32725768 [TBL] [Abstract][Full Text] [Related]
12. MicroRNA-301b-3p contributes to tumour growth of human hepatocellular carcinoma by repressing vestigial like family member 4. Guo Y; Yao B; Zhu Q; Xiao Z; Hu L; Liu X; Li L; Wang J; Xu Q; Yang L; Huang D J Cell Mol Med; 2019 Aug; 23(8):5037-5047. PubMed ID: 31207037 [TBL] [Abstract][Full Text] [Related]
13. LncRNA NNT-AS1 promotes non-small cell lung cancer progression through regulating miR-22-3p/YAP1 axis. He W; Zhang Y; Xia S Thorac Cancer; 2020 Mar; 11(3):549-560. PubMed ID: 31923353 [TBL] [Abstract][Full Text] [Related]
14. The POU2F1/miR-4490/USP22 axis regulates cell proliferation and metastasis in gastric cancer. Xiao Y; Liu S; Li J; Dai W; Tang W; Xiang L; Zhang W; Lin J; Wang J; Wu X; Liu G; Liu Y; Chen Y; Zhu H; Wang Y; Lin Z; Yang Q; Chen T; Sun Y; Li A; Xiong J; Wang J Cell Oncol (Dordr); 2020 Dec; 43(6):1017-1033. PubMed ID: 32857323 [TBL] [Abstract][Full Text] [Related]
15. SATB1 3'-UTR and lncRNA-UCA1 competitively bind to miR-495-3p and together regulate the proliferation and invasion of gastric cancer. Sun L; Liu L; Yang J; Li H; Zhang C J Cell Biochem; 2019 Apr; 120(4):6671-6682. PubMed ID: 30368875 [TBL] [Abstract][Full Text] [Related]
16. UBE2C, Directly Targeted by miR-548e-5p, Increases the Cellular Growth and Invasive Abilities of Cancer Cells Interacting with the EMT Marker Protein Zinc Finger E-box Binding Homeobox 1/2 in NSCLC. Jin D; Guo J; Wu Y; Du J; Wang X; An J; Hu B; Kong L; Di W; Wang W Theranostics; 2019; 9(7):2036-2055. PubMed ID: 31037155 [No Abstract] [Full Text] [Related]
17. PKP2 induced by YAP/TEAD4 promotes malignant progression of gastric cancer. Liu Y; Lu Y; Xing Y; Zhu W; Liu D; Ma X; Wang Y; Jia Y Mol Carcinog; 2024 Sep; 63(9):1654-1668. PubMed ID: 38804704 [TBL] [Abstract][Full Text] [Related]
18. M2 macrophage-derived extracellular vesicles promote gastric cancer progression via a microRNA-130b-3p/MLL3/GRHL2 signaling cascade. Zhang Y; Meng W; Yue P; Li X J Exp Clin Cancer Res; 2020 Jul; 39(1):134. PubMed ID: 32660626 [TBL] [Abstract][Full Text] [Related]
19. LncRNA MT1JP Suppresses Gastric Cancer Cell Proliferation and Migration Through MT1JP/MiR-214-3p/RUNX3 Axis. Xu Y; Zhang G; Zou C; Zhang H; Gong Z; Wang W; Ma G; Jiang P; Zhang W Cell Physiol Biochem; 2018; 46(6):2445-2459. PubMed ID: 29742512 [TBL] [Abstract][Full Text] [Related]
20. miR-148b-3p inhibits gastric cancer metastasis by inhibiting the Dock6/Rac1/Cdc42 axis. Li X; Jiang M; Chen D; Xu B; Wang R; Chu Y; Wang W; Zhou L; Lei Z; Nie Y; Fan D; Shang Y; Wu K; Liang J J Exp Clin Cancer Res; 2018 Mar; 37(1):71. PubMed ID: 29587866 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]